产品详情
Targets
Target | Value |
---|---|
CDK4/CyclinD1 | ki: 1nM |
CDK1/CyclinB | ki: 2nM |
CDK2/CyclinE | ki: 3nM |
PKA | ki: >5μM |
PKB | ki: >5μM |
PKCα | ki: >5μM |
PKCβ | ki: >5μM |
Fyn | ki: >5μM |
EphB3 | ki: >5μM |
SGK | ki: >5μM |
KDR | ki: >5μM |
FGFR | ki: >5μM |
EGFR | ki: >5μM |
PDGFR | ki: >5μM |
IGFR | ki: >5μM |
Src | ki: >5μM |
FAK | ki: >5μM |
AuroraA | ki: >5μM |
GSK-3β | ki: 8μM |
p38 | ki: >50μM |
MAPK2 | ki: >50μM |
In vitro (25°C) | DMSO | 56 mg/mL (126.85 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 1% hydroxyethyl cellulose+0.2% Tween 80 | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.65 mL | 113.26 mL | 226.53 mL |
0.5 mM | 4.53 mL | 22.65 mL | 45.31 mL |
1 mM | 2.27 mL | 11.33 mL | 22.65 mL |
5 mM | 0.45 mL | 2.27 mL | 4.53 mL |
*The above data is based on the productmolecular weight 441.45. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11190 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 441.45 |
Formula | C18H21F2N5O4S |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 741713-40-6 |
Synonyms | R-547 |
SMILES | COC1=C(C(=C(C=C1)F)F)C(=O)C2=CN=C(N=C2N)NC3CCN(CC3)S(=O)(=O)C |
产品标签
Product Questions
Product Questions
BMS-863233 (XL-413)
BMS-863233,也称为XL-413,是一种具有潜在抗肿瘤活性的细胞分裂周期7同系物(CDC7)激酶抑制剂。
PHA-767491
PHA-767491是一种有效的,具有ATP竞争性的双重cdc7/cdk9抑制剂 (IC50值分别为10和34 nM),可防止DNA复制的启动。
SNS-032 (BMS-387032)
SNS-032(BMS-387032)是细胞周期蛋白依赖性激酶(Cdks)2、7和9的高度选择性和有效抑制剂,具有体外生长抑…
BAY 1000394 (Roniciclib)
BAY 1000394 (Roniciclib)是一种口服生物利用细胞周期蛋白依赖性激酶(CDK)抑制剂,具有潜在的抗肿瘤活性。